Search

Makiko S Fliss

from Cranbury, NJ
Age ~58
Get Report
Also known as:
Makiko Suzuki Fliss, Nakiko N Fliss, Makiko Suzuki-Fliss, Makiko S Suzuki, Maki Fliss, Fliss Maki
Related to:
Sarah E Lovelace, 30Albert E FlissMaria F Ventura, 66Chiho Suzuki, 50Albert E Fliss, 64Nicholas FlissIrene P Fliss, 95Irene P Fliss
Connected to:
Deborah A Fliss, 69Ian Fliss, 42Margaret M Fliss, 67Nancy L Fliss, 66Stasia A Fliss, 102Stephen B Flitcraft, 53Oscar P Flite, 76Steven H Flitman, 73Charlene M Flitsch, 43Earl T Flitsch, 42

Makiko Fliss Phones & Addresses

  • Cranbury, NJ
  • 6491 Lacelike Row, Columbia, MD 21045
  • New York, NY
  • 36 Senior Ave, Mahopac, NY 10541 (845) 208-3581
  • Gainesville, FL
  • Glen Burnie, MD
  • Bethel, CT
  • 12 Ryan Rd, Cranbury, NJ 08512 (609) 409-4387

Work

Company: Bristol-myers squibb Jul 2006 Position: Commerical organization

Education

Degree: MBA School / High School: Pace University - Lubin School of Business 2007 to 2009 Specialities: Strategic Management

Skills

Strategic Planning • Business Development • Biotechnology • Forecasting • Pharmaceutical Industry • Market Research • Strategy • Business Intelligence • Drug Discovery • Business Analysis • Clinical Development • Leadership • Market Analysis • Management • Marketing Strategy • Start Ups • Cross Functional Team Leadership • Business Planning • R&D • Product Launch • Oncology • Lifesciences • Life Sciences

Languages

Japanese • English

Ranks

Certificate: Reiki Certification

Interests

Visioning • Environment • Energy Healing • Creation • Science and Technology • Animal Welfare • Arts and Culture • Health

Emails

f***[email protected]

Industries

Professional Training & Coaching

Resumes

Resumes

Makiko Fliss Photo 1

Founder

View page
Location:
12 Ryan Rd, Cranbury, NJ 08512
Industry:
Professional Training & Coaching
Work:
Bristol-Myers Squibb since Jul 2006
Commerical Organization
Penwest Pharmaceuticals Jul 2005 - Jul 2006
Director Business Analysis & Market Research
TARO Pharmaceuticals Apr 2001 - Sep 2004
Director
Novascreen 2001 - 2001
Consultant
Virco Lab (Currently Johnson & Johnson) Jan 2000 - Apr 2001
Senior Scientist
Education:
Pace University - Lubin School of Business 2007 - 2009
MBA, Strategic Management Lubin Business School 2001 - 2008
MBA, Marketing The Johns Hopkins University School of Medicine 1997 - 1998
Postdoctoral, Oncology, Diagnostics, Genomics Mount Sinai School of Medicine Jun 1994 - May 1997
PhD, Biomedical Sciences Meiji University Apr 1986 - Apr 1990
BS, Animal Science, Breast Cancer Lab
Skills:
Strategic Planning
Business Development
Biotechnology
Forecasting
Pharmaceutical Industry
Market Research
Strategy
Business Intelligence
Drug Discovery
Business Analysis
Clinical Development
Leadership
Market Analysis
Management
Marketing Strategy
Start Ups
Cross Functional Team Leadership
Business Planning
R&D
Product Launch
Oncology
Lifesciences
Life Sciences
Interests:
Visioning
Environment
Energy Healing
Creation
Science and Technology
Animal Welfare
Arts and Culture
Health
Languages:
Japanese
English
Certifications:
Reiki Certification

Business Records

Name / Title
Company / Classification
Phones & Addresses
Makiko Fliss
Principal
Makikohandmade
Business Services at Non-Commercial Site
12 Ryan Rd, East Windsor, NJ 08512

Publications

Us Patents

Mitochondrial Dosimeter

View page
US Patent:
6605433, Aug 12, 2003
Filed:
Mar 15, 2000
Appl. No.:
09/525906
Inventors:
Makiko Fliss - Columbia MD
David Sidransky - Baltimore MD
Jin Jen - Brookville MD
Komelia Polyak - Brookline MA
Bert Vogelstein - Baltimore MD
Kenneth W. Kinzler - BelAir MD
Assignee:
The Johns Hopkins University - Baltimore MD
International Classification:
C12Q 168
US Classification:
435 6, 435 911, 435 912, 536 231, 536 243, 536 2433, 436504
Abstract:
Mitochondrial mutations occur as a product of contact of a person with an environmental pollutant. Mitochondrial mutations are readily detectable in body fluids. Measurement of mitochondrial mutations in body fluids can be used as a dosimeter to monitor exposure to the environmental pollutant. Mitochondrial mutations can also be detected in cancer patients. Probes and primers containing mutant mitochondrial sequences can be used to monitor patient condition.

Mitochondrial Dosimeter

View page
US Patent:
20040018538, Jan 29, 2004
Filed:
Jun 24, 2003
Appl. No.:
10/601692
Inventors:
Makiko Fliss - Columbia MD, US
David Sidransky - Baltimore MD, US
Jin Jen - Brookville MD, US
Kornelia Polyak - Brookline MA, US
Bert Vogelstein - Baltimore MD, US
Kenneth Kinzler - BelAir MD, US
Assignee:
Johns Hopkins University - Baltimore MD
International Classification:
C12Q001/68
US Classification:
435/006000
Abstract:
Mitochondrial mutations occur as a product of contact of a person with an environmental pollutant. Mitochondrial mutations are readily detectable in body fluids. Measurement of mitochondrial mutations in body fluids can be used as a dosimeter to monitor exposure to the environmental pollutant. Mitochondrial mutations can also be detected in cancer patients. Probes and primers containing mutant mitochondrial sequences can be used to monitor patient condition.

Mitochondrial Dosimeter

View page
US Patent:
20090124795, May 14, 2009
Filed:
Apr 10, 2008
Appl. No.:
12/100706
Inventors:
Makiko Fliss - Columbia MD, US
David Sidransky - Baltimore MD, US
Jin Jen - Brookville MD, US
Kornelia Polyak - Brookline MA, US
Bert Vogelstein - Baltimore MD, US
Kenneth W. Kinzler - BelAir MD, US
Assignee:
JOHNS HOPKINS UNIVERSITY - Baltimore MD
International Classification:
C07H 21/00
US Classification:
536 2431
Abstract:
Mitochondrial mutations occur as a product of contact of a person with an environmental pollutant. Mitochondrial mutations are readily detectable in body fluids. Measurement of mitochondrial mutations in body fluids can be used as a dosimeter to monitor exposure to the environmental pollutant. Mitochondrial mutations can also be detected in cancer patients. Probes and primers containing mutant mitochondrial sequences can be used to monitor patient condition.

Procedure For Preparing Gene Expression Libraries Enriched For Secretory Protein Genes

View page
US Patent:
60401443, Mar 21, 2000
Filed:
Jul 25, 1997
Appl. No.:
8/900347
Inventors:
Frank Carter Bancroft - Huntington NY
Makiko Fliss - New York NY
Assignee:
Mount Sinai School of Medicine - New York NY
International Classification:
C12Q 168
C12N 1563
US Classification:
435 6
Abstract:
The present invention relates to a method for producing a gene expression library enriched for a particular class of genes comprising (i) a nucleic acid preparation step and (ii) a polyclonal antiserum screening step, wherein both steps define the class of genes of interest. The method of the invention, using selection procedures directed not only at the underlying nucleic acid but also a functional attribute of the target class of proteins, may be used to produce gene expression libraries enriched for genes encoding a desired class of proteins, including, but not limited to, secretory proteins, cell cycle associated proteins, proteins defined by a particular subcellular location, tissue specific proteins, infection-related proteins, and non-infectious disease associated proteins.
Control profile
Makiko S Fliss from Cranbury, NJ, age ~58 Get Report